I. Introduction
Hypertensive disorders in pregnancy form a deadly triad with hemorrhage & infection, being a direct cause of maternal mortality worldwide. It complicates 5-10% of all pregnancies. [1] Of these hypertensive disorders, preeclampsia syndrome is the most ominous. Preeclampsia syndrome is clinical spectrum of worsening disease with attenuated manifestation to cataclysmic deterioration, life threatening for both mother & fetus. It also causes one tenth of maternal deaths in Asia and Africa and one Quarter of maternal deaths in Latin America. [2] Preeclampsia syndrome is a multiorgan dysfunction characterized by Blood pressure of ≥ 140/90 mm Hg and proteinuria after mid-gestation i.e. 20 weeks of pregnancy. Multiorgan involvement may include thrombocytopenia, renal dysfunction, hepatocellular necrosis, central nervous system perturbations, or pulmonary edema. It is leading cause of fetal growth restriction, intra uterine fetal demise and preterm birth. [3] Pregnancy is characterized by a series of metabolic changes that promote adipose tissue accretion in early gestation followed by insulin resistance and facilitated lipolysis in late pregnancy. In early pregnancy insulin secretion increases while insulin sensitivity is unchanged, decreased or may even increase. There is 50% decrease in insulin mediated glucose disposal & 200-250% increase in insulin secretion to maintain Euglycemia in mother. [4] "Evaluation And The insulin resistance syndrome provides a link between pregnancy induced hypertension and its risk factors and sequalae in both pregnancy & later life. [5] Preeclampsia and Gestational hypertension are associated with exaggerated hyperinsulnemia relative to normal pregnancy. Hyperinsulinemia in pregnancy predisposes to hypertension by increased sodium reabsorption and stimulation of sympathetic nervous system. Insulin resistance and / or associated hyperglycemia may impair endothelial function. [6] Many of the features of insulin resistance i.e. Hypertension, Hyperinsulinemia, Glucose intolerance, obesity, lipid abnormalities, increased leptin, increased TNFα, increased TPA and PA1-I, Elevated Testosterone and reduced SHBG are associated with preeclampsia. [5] Increased insulin resistance activates sympathetic nervous system leading to an increased expression of receptors for endothelin which results in increased blood pressure. Hyperinsulinemia induces hypertriglyceridemia, endothelial dysfunction and reduction in prostacyclin production. Insulin resistance may not be the cause of preeclampsia but is one of the pathogenic factors in genetically predisposed women. [7] Abnormal lipid metabolism seems important in pathogenesis of preeclampsia. Association of serum lipids with gestational proteinuric hypertension is highly suggestive of role for lipid profile analysis as diagnostic tool. [8] It has direct effect on endothelial dysfunction. Hypertension in pregnancy is supposed to be due to vasospastic phenomenon in kidney, uterus, placenta and brain. Altered lipid synthesis leads to decrease in PGI 2 ; TXA 2 ratioan important pathway in pathogenesis of preeclampsia. Increased triglycerides in preeclampsia may be deposited in uterine spiral arteries leading to endothelial dysfunction through generation of small dense LDL. [9] In addition hypertriglyceridemia is associated with hypercoagulability. [10] II. Aims & Objectives 
III. Material & Methods
• The present study was conducted in departments of Biochemistry and Obstetrics and Gynecology, Govt. Medical College, Patiala, Punjab w.e.f. June 2012 to May 2013 on 65 pregnant females. Patients were divided into study group and control group. • Study Group: 40 pregnant patients with pre-eclampsia at ≥ 20 weeks gestation. Study group was further divided into: non-severe preeclampsia and severe pre-eclampsia.
• Control Group: 25 pregnant normotensive women at ≥ 20 weeks gestation. All patients were subjected to routine hematological and biochemical investigation of pregnancy followed by special investigations i.e. fasting plasma insulin levels and lipid profile (serum cholesterol, triglycerides, HDL, LDL & VLDL). Evaluation of insulin resistance was done using homeostasis model assessment HOMA.
Fasting plasma glucose mmol / L × Fasting Plasma Insulin µmol/L 22.5 Data was compiled and analysed for statistical significance.
IV. Results
Mean age in the study group 26.6±4.48 years and 25.0±2.79 years in control group was comparable. 52.5 patients in study group and 52% in control group were primigravida. Mean period of gestation was 33.38 ± 2.53 weeks in study group and 29.48 ± 2.50 weeks in control group (Table 1) .
• A total of 23 cases (57.5%) in study group had severe preeclampsia while 17(42.5%) had non severe preeclampsia (Table 2a) , Mean systolic blood pressure in study group was 156.00±14.10 mmHg against 114.40 mmHg in control group. Mean diastolic blood pressure was 105.25 mmHg and 76.00 mmHg in study and control group. The difference in two groups was statistically highly significant p<0.001 (Table  2b) • Serum creatinine, uric acid and LFT were significantly higher and platelet count lower in study group (Table 3 ).
• Mean fasting plasma insulin levels in study group was 53.31 µIU/ml compared to 16.35 µIU/ml in control group, difference being statistically highly significant (p<0.001). Mean fasting plasma insulin level in severe preeclampsia was 72.33 µIU/ml compared to 39.25 ± 12.22 µIU/ml in Non severe preeclampsia. However hemoglobin and fasting plasma glucose levels were comparable in both the groups (Table 4 ).
• Homa IR index in study group was 10.33 and 3.04 in control group, difference being statistically highly significant (p<0.001), Homa IR Index in severe preeclampsia was 13.83±3.23 and non-severe preeclampsia 7.74±2.37, significantly raised compared to control group (Table 5) .
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• Lipid profile (serum cholesterol, triglyceride, HDL, LDL, VLDL) were significantly raised in non severe and severe preeclampsia compared to control group (p value < 0.001). With severity of preeclampsia, total cholesterol also rises, may be result of oxidative stress contributing to atherogenesis and pathogenesis of preeclampsia. A positive correlation was also found between serum triglycerides and LDL with severity of preeclampsia, p<0.001 (Table 7) .
V. Discussion
Mean age of preeclampsia in our study group 26.60 ± 4.48 years was comparable with Pashupathy et al 2009 and Islam et al 2010 i.e. 27 years and 24 years respectively. [11, 12] 52.5% women with preeclampsia in our study group were primigravida while Dhananjaya 2011 reported 64% women with preeclampsia to be primigravida in his study. [13] Mean period of gestation in study group was 32.38 ± 2.53 weeks and 29.48±2.50 weeks in control group respectively while Pashupathy et al 2009 in his study reported 34.3 weeks and 35 weeks respectively. [11] Plasma insulin levels in our study group were very high 53.30 ± 22.52 compared to 16.35 ± 5.72 µIU/ml in control group. Difference being statistically highly significant. Plasma insulin levels were found to be higher in the studies done by Xu (Table 5c) . [14, 15, 16, 17] Mean fasting plasma insulin levels in severe preeclampsia were significantly higher 72.33 ± 19.16 µIU/ml than nonsevere preeclampsia 39.25 ± 12.22µIU/ml]. Exaggerated hyperinsulinemia relative to normal pregnancy is well described in women with established preeclampsia or gestational hypertension being consistent with hypothesis that insulin resistance may play a role in PIH pathogenesis. Mean value of HOMA IR Index in preeclampsia was higher (10.33) than control group (3.04) the difference was statistically highly significant (p value <0.001) Mean HOMA IR, Index in severe preeclampsia was 13.83 compared to 7.74 in non severe preeclampsia difference being highly significant (p<0.001). Kocigyit et al (2004) also reported similar findings. [18] Serum cholesterol levels and lipid profile were significantly higher in severe and non severe preeclampsia compared to normal pregnant women in our study. Similar findings were observed by Pashupathi et al 2009. [11] Physiological insulin resistance is exaggerated in preeclampsia. Gestational insulin resistance may accentuate suppression of lipoprotein lipase activity and increase mobilization of free fatty acids from visceral adipocytes, explaining hypercholestremia in preeclampsia. [19] There was highly significant correlation of fasting plasma insulin, HOMA-IR index with serum cholesterol, serum triglycerides, LDL and VLDL levels, all being significantly raised in preeclampsia. Similar observations were made by Asemi et al 2013. [20] 
VI. Conclusion
Patients with preeclampsia had significant increase in fasting plasma insulin levels, insulin resistance and significant increase in lipid profile levels (serum cholesterol triglycerides, HDL, LDL and VLDL) compared to normotensive pregnant females. Increased fasting insulin levels, Increased insulin resistance as well as raised lipid profile parameters are diagnostic and prognostic tool for early diagnosis and management of preeclampsia there by reducing maternal morbidity and mortality and adverse fetal outcome. Further, studies on larger population may be a step towards achievement of sustainable development goal-3 in decreasing maternal mortality to 70 per 100,000 live births by 2030. • Mean age in the study group and control group was 26.6 ± 4.48 and 25.0 ± 2.79 years respectively was comparable.
• 52% patients in each study and control group were primigravida.
• Mean gestation in study group i.e. 32.38 ± 2.53 weeks and 29.48 ± 2.50 in control group was comparable. Serum creatnine /uric acid / SGOT/PT were significantly raised and platelet count decreased in study group compared to control group. • Hemoglobin level and Fasting Plasma Glucose levels were comparable in study and control group.
• Mean fasting plasma insulin level in study group was 53.31µlU/ml compared to 16.35 µIU/ml in control group. Difference in two groups is statistically highly significant. (p <0.001) • Difference in mean fasting plasma insulin levels between severe and non-severe preeclampisa was also highly significant (p<0.001) 
